冠状动脉瘤患者改良电休克治疗的麻醉管理：一例报告
Anesthetic management of modified electroconvulsive therapy for a patient with coronary aneurysms: a case report.
作者信息
Nakayama Riho, Yoshida Takuya, Obata Norihiko, Mizobuchi Satoshi
机构信息
Department of Anesthesiology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe city, Hyogo, 650-0017, Japan.
出版信息
JA Clin Rep. 2019 Nov 22;5(1):76. doi: 10.1186/s40981-019-0298-y.
BACKGROUND
Modified electroconvulsive therapy (m-ECT) is utilized worldwide as an effective treatment for drug-resistant psychiatric disorders. However, during m-ECT, treatment of hypotension and hypertension in response to rapid hemodynamic changes is required. We used noninvasive continuous blood pressure monitoring system for continuous hemodynamic measurement during m-ECT.
CASE PRESENTATION
The patient was a 77-year-old man with depression complicated by coronary artery aneurysms (CAAs). We managed general anesthesia during m-ECT by using the ClearSight™ system (Edwards Lifesciences Corp, Irvine, CA, USA) for hemodynamic measurement. As a result, we performed a total of 10 m-ECTs. No rupture of CAAs or myocardial ischemia occurred and depressive symptoms improved.
CONCLUSION
We successfully managed the anesthesia in m-ECT for a depressed patient with CAAs without complications by using the ClearSight™ system, which was used for the effective management of circulatory fluctuations.
背景
改良电休克疗法（m-ECT）在全球范围内被用作治疗耐药性精神疾病的有效方法。然而，在m-ECT期间，需要应对快速的血流动力学变化来治疗低血压和高血压。我们在m-ECT期间使用无创连续血压监测系统进行连续血流动力学测量。
病例报告
患者为一名77岁男性，患有抑郁症并伴有冠状动脉瘤（CAA）。我们在m-ECT期间通过使用ClearSight™系统（美国加利福尼亚州尔湾市爱德华兹生命科学公司）进行血流动力学测量来管理全身麻醉。结果，我们总共进行了10次m-ECT。未发生CAA破裂或心肌缺血，抑郁症状得到改善。
结论
我们通过使用ClearSight™系统成功地对一名患有CAA的抑郁症患者进行了m-ECT麻醉管理，未出现并发症，该系统用于有效管理循环波动。
Zotero 插件